FDA Raises Safety Warnings against Popular Drug Prescribed During Pregnancy

The Food and Drug Administration flags risks on a popular pregnancy treatment to prevent pregnant women from giving premature birth. According to FDA, pregnant women must not take the drug terbutaline (as injections) for more than three days. FDA is raising stronger safety warnings against this pregnancy drug "because of the potential for serious maternal heart problems and death". This pregnancy drug is now requiring the most serious type of warning that FDA can add to a drug's label –

Read more ...